Advertisement

Ads Placeholder
Loading...

Incyte Corporation

INCY•NASDAQ
Healthcare
Biotechnology
$95.93
$1.63(1.73%)
U.S. Market opens in 33h 50m

Incyte Corporation (INCY) Stock Overview

Explore Incyte Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.1B
P/E Ratio14.72
EPS (TTM)$6.41
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$86.04
3 Months$102.87
1 Year Target$118.06

INCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Incyte Corporation (INCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.72 and a market capitalization of 19.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.73%
5-Day Change
3.96%
1-Month Change
-2.18%
3-Month Change
-5.41%
6-Month Change
10.45%
Year-to-Date (YTD) Change
-5.41%
1-Year Change
53.59%
3-Year Change
32.03%
5-Year Change
15.23%
All-Time (Max) Change
5016.27%

Contact Information

https://www.incyte.com
302 498 6700
1801 Augustine Cut-Off, Wilmington, DE, 19803

Company Facts

26,170 Employees
IPO DateNov 4, 1993
CountryUS
Actively Trading

Frequently Asked Questions